![Akira Yamada](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 60 430 $ al 31/05/2026
Akira Yamada has held the following positions in his career: Director & Professor at Kurume University since 2016, and Director at BrightPath Biotherapeutics Co., Ltd. since 2004.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/03/2025 | 185.000 ( 0,13 % ) | 60 430 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BRIGHTPATH BIOTHERAPEUTICS CO., LTD. | Director/Miembro de la Junta | 01/05/2003 |
Kurume University
 Kurume University Other Consumer ServicesConsumer Services Functions as a College/University | Director/Miembro de la Junta | 01/04/2016 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Kurume University
Kurume University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BrightPath Biotherapeutics Co., Ltd.
 BrightPath Biotherapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Provides research, development, production, and sale of cancer immunotherapies | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
